Ovarian Non-Hodgkin’s Lymphoma from a Regional Cancer Centre in South India

Author(s): Suresh Babu, Usha Amirtham, Lokesh K.N, Govind Babu.K, Lakshmaiah K.C, Lokanatha Dasappa, C.S. Premalata, Linu Abraham Jacob, Rudresh AH, Rajeev LK, Venugopal Arroju

Primary Non-Hodgkin’s Lymphoma of Ovary is a rare cancer. There is limited data in Indian population. Hence we undertook this retrospective observational study at our center in Southern India. This study includes 5 consecutive cases diagnosed as Primary Non-Hodgkin’s Lymphoma of Ovary between January 2009 and December 2015. Primary Non-Hodgkin’s lymphoma (NHL) of the ovary is rare with an incidence in the literature of 0.5% of NHL and 1.5% of ovarian tumours. Diffuse large B-cell type accounts for about 20% of PONHL. We studied five cases of primary ovarian NHL. All cases were diffuse large B-cell lymphoma of ovary. The patients ranged in age from 41years to 59 years with median age of presentation 50 years. Pain abdomen was the most common symptom (3/5-60%). According to Ann Arbor stage- Advanced stage ( IVE) was seen in 3 patients ( 60 %) and the rest 2 patients (40% ) had stage IE. 4 patients had Eastern co-operative oncology group (ECOG) performance status -1 and 1 patient had ECOG PS -2. B symptoms were seen in 3 out of 5 patients (60 %). According to IPI, 3 patients (60%) were in low intermediate risk and 2 patients (40%) had low risk score. 1 case was positive for BCL-6, 1 case was positive for CD10, 3 cases were positive for BCL-2, and 4 cases were positive for CD 20 . Patients were treated by various combinations of surgery, chemotherapy, and radiotherapy. Overall survival ranged from 6 months to 41 months with median OS of 23 months.

1. Vang R, Medeiros LJ, Fuller GN, Sarris AH, Deavers M. Non-Hodgkin’s lymphoma involving the gynecologic tract. A review of 88 cases. Adv Anat Pathol 2001;8:200–17.
2. Monterroso V, Jaffe ES, Merino MJ, Medeiros LJ. Malignant lymphomas involving the ovary. Am J Surg Pathol 1993; 17:154–70.
3. Osborne BM, Robboy SJ. Lymphomas or leukemia presenting as ovarian tumors. An analysis of 42 cases. Cancer 1983; 52:1933–43.
4. Suzuki T, Sasano H, Takaya R, Fukaya T, Yajima A, Date F, et al. Leukocytes in normal-cycling human ovaries: immunohistochemical distribution and characterization. Hum Reprod1998;13:2186–91
5. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosaassociated lymphoid tissue to Helicobacter pylori. Lancet 1993; 4:571–4.
6. M. A. Dimopoulos, D. Daliani, W. Pugh, D. Gershenson, F.Cabanillas, and A. H. Sarris, “Primary ovarian non-Hodgkin’s lymphoma: outcome after treatment with combination chemotherapy,”Gynecologic Oncology, vol. 64, no. 3, pp. 446–450, 1997.
7. V. Monterroso, E. S. Jaffe, M. J. Merino, and L. J. Medeiros,“Malignant lymphomas involving the ovary: a clinicopathologic analysis of 39 cases,” American Journal of Surgical Pathology, vol.17, no. 2, pp. 154–170, 1993.
8. H. Fox, F. A. Langley, A. D. T. Govan, S. A. Hill, andM.H. Bennett,“Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases,” British Journal of Obstetrics and Gynaecology, vol. 95, no. 4, pp. 386–390, 1988.
9. R. Vang, L. J. Medeiros, R. A. Warnke, J. P. Higgins, and M. T.Deavers, “Ovarian non-Hodgkin’s lymphoma: a clinicopathologic study of eight primary cases,” Modern Pathology, vol. 14, no. 11, pp. 1093–1099, 2001.
10. A. S.Weingertner, D. Hamid, M. N. Roedlich, and J. J. Baldauf, “Non-Hodgkin malignant lymphoma revealed by an ovarian tumor: case report and review of the literature,” Gynecologic Oncology, vol. 95, no. 3, pp. 750–754, 2004.
11. P. Feugier, A. Van Hoof, C. Sebban et al., “Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the groupe d’etude deslymphomes de l’adulte,” Journal of Clinical Oncology, vol. 23, no.18, pp. 4117–4126, 2005.
12. N. Sakurai, K. Tateoka, J. Taguchi, and T. Terada, “Primary precursor B-cell lymphoblastic lymphoma of the ovary: case report and review of the literature,” International Journal of Gynecological Pathology, vol. 27, no. 3, pp. 412–417, 2008.
13. M. A. Dimopoulos, D. Daliani, W. Pugh, D. Gershenson, F.Cabanillas, and A. H. Sarris, “Primary ovarian non-Hodgkin’slymphoma: outcome after treatment with combination chemotherapy,” Gynecologic Oncology, vol. 64, no. 3, pp. 446–450, 1997